| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OSE Immunotherapeutics SA (PA: OSE)
OSE Technical Analysis
4
| As on 12th Mar 2025 OSE STOCK Price closed @ 6.67 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.37 & Strong Buy for SHORT-TERM with Stoploss of 4.28 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OSESTOCK Price
| Open | 6.90 | Change | Price | % |
| High | 7.07 | 1 Day | 0.88 | 15.20 |
| Low | 6.53 | 1 Week | 0.08 | 1.21 |
| Close | 6.67 | 1 Month | 0.16 | 2.46 |
| Volume | 686111 | 1 Year | 2.33 | 53.69 |
| 52 Week High 10.74 | 52 Week Low 3.20 | ||||
PA France Most Active Stocks
| ATO | 0.00 | % |
| ALVER | 0.00 | % |
| ALEUP | 0.02 | 0.00% |
| FTI | 5.91 | -1.66% |
| VIEDS | 0.72 | 4.35% |
| LAT | 0.02 | 0.00% |
| ALNRG | 0.01 | % |
| ALALO | 0.00 | % |
| ORA | 11.75 | -0.17% |
| ENGI | 17.20 | 0.88% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
| OSE Daily Charts |
OSE Intraday Charts |
Whats New @ Bazaartrend |
OSE Free Analysis |
|
|
OSE Important Levels Intraday
| RESISTANCE | 7.71 |
| RESISTANCE | 7.38 |
| RESISTANCE | 7.17 |
| RESISTANCE | 6.96 |
| SUPPORT | 6.38 |
| SUPPORT | 6.17 |
| SUPPORT | 5.96 |
| SUPPORT | 5.63 |
OSE Forecast March 2025
| 4th UP Forecast | 8.29 |
| 3rd UP Forecast | 7.77 |
| 2nd UP Forecast | 7.45 |
| 1st UP Forecast | 7.13 |
| 1st DOWN Forecast | 6.21 |
| 2nd DOWN Forecast | 5.89 |
| 3rd DOWN Forecast | 5.57 |
| 4th DOWN Forecast | 5.05 |
OSE Weekly Forecast
| 4th UP Forecast | 8.29 |
| 3rd UP Forecast | 7.77 |
| 2nd UP Forecast | 7.45 |
| 1st UP Forecast | 7.13 |
| 1st DOWN Forecast | 6.21 |
| 2nd DOWN Forecast | 5.89 |
| 3rd DOWN Forecast | 5.57 |
| 4th DOWN Forecast | 5.05 |
OSE Forecast2025
| 4th UP Forecast | 22.97 |
| 3rd UP Forecast | 17.74 |
| 2nd UP Forecast | 14.51 |
| 1st UP Forecast | 11.28 |
| 1st DOWN Forecast | 2.06 |
| 2nd DOWN Forecast | -1.17 |
| 3rd DOWN Forecast | -4.4 |
| 4th DOWN Forecast | -9.63 |
OSE Immunotherapeutics SA ( PA France Symbol : OSE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OSE Business Profile
OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; CoVepiT, a prophylactic vaccine against the SARS-CoV-2 virus; BI 765063, which is in Phase I clinical trial to treat solid tumors; and BiCKI, a novel bispecific checkpoint inhibitor platform, targeting PD-1 and innovative targets to fight primary and secondary resistance mechanisms developed by cancers. The company's products also comprise OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis; and OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, Boehringer Ingelheim, Servier, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA is headquartered in Nantes, France. Address: 22, boulevard Benoni Goullin, Nantes, France, 44200
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service